278 related articles for article (PubMed ID: 24041885)
1. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
Draper MP; Weir S; Macone A; Donatelli J; Trieber CA; Tanaka SK; Levy SB
Antimicrob Agents Chemother; 2014; 58(3):1279-83. PubMed ID: 24041885
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
Macone AB; Caruso BK; Leahy RG; Donatelli J; Weir S; Draper MP; Tanaka SK; Levy SB
Antimicrob Agents Chemother; 2014; 58(2):1127-35. PubMed ID: 24295985
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
Pfaller MA; Huband MD; Shortridge D; Flamm RK
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071045
[TBL] [Abstract][Full Text] [Related]
4. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study.
Xiao M; Huang JJ; Zhang G; Yang WH; Kong F; Kudinha T; Xu YC
BMC Microbiol; 2020 Nov; 20(1):350. PubMed ID: 33198626
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
Huband MD; Pfaller MA; Shortridge D; Flamm RK
J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
[TBL] [Abstract][Full Text] [Related]
7. Microbiology and Preclinical Review of Omadacycline.
Karlowsky JA; Steenbergen J; Zhanel GG
Clin Infect Dis; 2019 Aug; 69(Suppl 1):S6-S15. PubMed ID: 31367743
[TBL] [Abstract][Full Text] [Related]
8. Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
Cho JC; Childs-Kean LM; Zmarlicka MT; Crotty MP
Drugs Today (Barc); 2018 Mar; 54(3):209-217. PubMed ID: 29771255
[TBL] [Abstract][Full Text] [Related]
9. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Tanaka SK; Steenbergen J; Villano S
Bioorg Med Chem; 2016 Dec; 24(24):6409-6419. PubMed ID: 27469981
[TBL] [Abstract][Full Text] [Related]
10. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.
Villano S; Steenbergen J; Loh E
Future Microbiol; 2016 Oct; 11():1421-1434. PubMed ID: 27539442
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018.
Dong D; Zheng Y; Chen Q; Guo Y; Yang Y; Wu S; Zhu D; Deng D; Bradford PA; Reinhart H; Hu F
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1559-1572. PubMed ID: 32356026
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetic evaluation of omadacycline (Oral Only Dosing Regimen) for the treatment of Community-Acquired Bacterial Pneumonia (CABP).
Cilloniz C; Torres A
Expert Opin Drug Metab Toxicol; 2023 Sep; 19(9):569-576. PubMed ID: 37728376
[TBL] [Abstract][Full Text] [Related]
13. Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
Mendes RE; Huband MD; Streit JM; Castanheira M; Flamm RK
Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115054. PubMed ID: 32376058
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S
Antimicrob Agents Chemother; 2015 Nov; 59(11):7044-53. PubMed ID: 26349824
[TBL] [Abstract][Full Text] [Related]
15. Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants.
Fluit AC; van Gorkum S; Vlooswijk J
Diagn Microbiol Infect Dis; 2019 May; 94(1):78-80. PubMed ID: 30583881
[TBL] [Abstract][Full Text] [Related]
16. Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.
Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993854
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.
Pfaller MA; Huband MD; Shortridge D; Flamm RK
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378719
[TBL] [Abstract][Full Text] [Related]
18. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):143-147. PubMed ID: 29157954
[TBL] [Abstract][Full Text] [Related]
19. Omadacycline Enters the Ring: A New Antimicrobial Contender.
Barber KE; Bell AM; Wingler MJB; Wagner JL; Stover KR
Pharmacotherapy; 2018 Dec; 38(12):1194-1204. PubMed ID: 30290000
[TBL] [Abstract][Full Text] [Related]
20. Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations.
Watkins RR; Deresinski S
Clin Infect Dis; 2019 Aug; 69(5):890-896. PubMed ID: 30893428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]